Abstract
Tobacco use and exposure are preventable causes of morbidity and mortality. Whereas the impact of this public health issue is well described in adults with kidney disease, its role in the pediatric chronic kidney disease (CKD) population is largely unknown. This review discusses the prevalence of tobacco use and exposure in children with CKD, updates the reader on how tobacco affects the kidney, and presents intervention strategies relevant to this patient population.
References
Department of Heallth and Human Services (US). How Tobacco Smoke Causes Disease: The biology and behavioral basis for smoking-attributable disease: A report of the surgeon general. Atlanta, GA: Department of Health and Human Services (US), Centers for disease Control and Prevention, National Center For Chronic Disease Prevention and Health Promation, Office on Smoking and Health, 2010
Centers for Disease Control and Prevention (CDC) (2011) Current cigarette smoking prevalence among working adults–United States, 2004–2010. MMWR Morb Mortal Wkly Rep 60:1305–1309
Centers for Disease Control and Prevention (CDC) (2012) Current tobacco use among middle and high school students–United States, 2011. MMWR Morb Mortal Wkly Rep 61:581–585
de Mattos AM, Prather J, Olyaei AJ, Shibagaki Y, Keith DS, Mori M, Norman DJ, Becker T (2006) Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int 70:757–764
Omoloja A, Jerry-Fluker J, Ng DK, Abraham AG, Furth S, Warady BA, Mitsnefes M (2013) Secondhand smoke exposure is associated with proteinuria in children with chronic kidney disease. Pediatr Nephrol 28:1243–1251
Omoloja A, Chand D, Greenbaum L, Wilson A, Bastian V, Ferris M, Bernert J, Stolfi A, Patel H (2011) Cigarette smoking and second-hand smoking exposure in adolescents with chronic kidney disease: a study from the Midwest pediatric nephrology consortium. Nephrol Dial Transplant 26:908–913
Tyc VL, Throckmorton-Belzer L (2006) Smoking rates and the state of smoking interventions for children and adolescents with chronic illness. Pediatrics 118:e471–e487
Yavuz A, Tuncer M, Gurkan A, Demirbas A, Suleymanlar G, Ersoy F, Yakupoglu G (2004) Cigarette smoking in renal transplant recipients. Transplant Proc 36:108–110
Kasiske BL, Klinger D (2000) Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 11:753–759
Mc Causland FR, Brunelli SM, Waikar SS (2012) Association of smoking with cardiovascular and infection-related morbidity and mortality in chronic hemodialysis. Clin J Am Soc Nephrol 7:1827–1835
Stack AG, Murthy BV (2010) Cigarette use and cardiovascular risk in chronic kidney disease: an unappreciated modifiable lifestyle risk factor. Semin Dial 23:298–305
Elders MJ, Perry CL, Eriksen MP, Giovino GA (1994) The report of the surgeon general: preventing tobacco use among young people. Am J Public Health 84:543–547
Centers for Disease Control and Prevention (CDC) (2008) Disparities in secondhand smoke exposure–united states, 1988–1994 and 1999–2004. MMWR Morb Mortal Wkly Rep 57:744–747
Centers for Disease Control and Prevention (CDC) (2007) Exposure to secondhand smoke among students aged 13–15 years–worldwide, 2000–2007. MMWR Morb Mortal Wkly Rep 56:497–500
Hogan SL, Vupputuri S, Guo X, Cai J, Colindres RE, Heiss G, Coresh J (2007) Association of cigarette smoking with albuminuria in the United States: the third national health and nutrition examination survey. Ren Fail 29:133–142
Maeda I, Hayashi T, Sato KK, Koh H, Harita N, Nakamura Y, Endo G, Kambe H, Fukuda K (2011) Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol 6:2462–2469
Garcia-Esquinas E, Loeffler LF, Weaver VM, Fadrowski JJ, Navas-Acien A (2013) Kidney function and tobacco smoke exposure in US adolescents. Pediatrics 131:e1415–e1423
Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, Inoue K, Uehata T, Kaneko T, Okada N, Moriyama T, Horio M, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y (2010) Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis 56:313–324
Orth SR, Schroeder T, Ritz E, Ferrari P (2005) Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 20:2414–2419
Zitt N, Kollerits B, Neyer U, Mark W, Heininger D, Mayer G, Kronenberg F, Lhotta K (2007) Cigarette smoking and chronic allograft nephropathy. Nephrol Dial Transplant 22:3034–3039
Sung RS, Althoen M, Howell TA, Ojo AO, Merion RM (2001) Excess risk of renal allograft loss associated with cigarette smoking. Transplantation 71:1752–1757
Jaimes EA, Tian RX, Raij L (2007) Nicotine: the link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol 292:H76–H82
Obert DM, Hua P, Pilkerton ME, Feng W, Jaimes EA (2011) Environmental tobacco smoke furthers progression of diabetic nephropathy. Am J Med Sci 341:126–130
Boor P, Casper S, Celec P, Hurbankova M, Beno M, Heidland A, Amann K, Sebekova K (2009) Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amosite. J Cell Mol Med 13:4484–4491
Yu CC, Lin JL, Lin-Tan DT (2004) Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol 15:1016–1022
Schwerdt G, Gordjani N, Benesic A, Freudinger R, Wollny B, Kirchhoff A, Gekle M (2006) Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells. Pediatr Nephrol 21:60–67
Jaimes EA, DeMaster EG, Tian RX, Raij L (2004) Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 24:1031–1036
Orth SR, Hallan SI (2008) Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients–absence of evidence or evidence of absence? Clin J Am Soc Nephrol 3:226–236
Le-Ha C, Beilin LJ, Burrows S, Huang RC, Oddy WH, Hands B, Mori TA (2013) Gender difference in the relationship between passive smoking exposure and HDL-cholesterol levels in late adolescence. J Clin Endocrinol Metab 98:2126–2135
Feldman J, Shenker IR, Etzel RA, Spierto FW, Lilienfield DE, Nussbaum M, Jacobson MS (1991) Passive smoking alters lipid profiles in adolescents. Pediatrics 88:259–264
Wilkinson JD, Lee DJ, Arheart KL (2007) Secondhand smoke exposure and C-reactive protein levels in youth. Nicotine Tob Res 9:305–307
Pijanowska M, Zajaczkowska M (2004) Passive smoking and patterns of 24-hour ambulatory blood pressure in healthy children. Pol Merkur Lekarski 16:320–322
Simonetti GD, Schwertz R, Klett M, Hoffmann GF, Schaefer F, Wuhl E (2011) Determinants of blood pressure in preschool children: the role of parental smoking. Circulation 123:292–298
Kallio K, Jokinen E, Hamalainen M, Saarinen M, Volanen I, Kaitosaari T, Viikari J, Ronnemaa T, Simell O, Raitakari OT (2009) Decreased aortic elasticity in healthy 11-year-old children exposed to tobacco smoke. Pediatrics 123:e267–e273
Kallio K, Jokinen E, Raitakari OT, Hamalainen M, Siltala M, Volanen I, Kaitosaari T, Viikari J, Ronnemaa T, Simell O (2007) Tobacco smoke exposure is associated with attenuated endothelial function in 11-year-old healthy children. Circulation 115:3205–3212
Makris TK, Thomopoulos C, Papadopoulos DP, Bratsas A, Papazachou O, Massias S, Michalopoulou E, Tsioufis C, Stefanadis C (2009) Association of passive smoking with masked hypertension in clinically normotensive nonsmokers. Am J Hypertens 22:853–859
Barnoya J, Glantz SA (2005) Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 111:2684–2698
Holmberg T, Bech M, Curtis T, Juel K, Gronbaek M, Brixen K (2011) Association between passive smoking in adulthood and phalangeal bone mineral density: results from the KRAM study–the Danish health examination survey 2007–2008. Osteoporos Int 22:2989–2999
Blum M, Harris SS, Must A, Phillips SM, Rand WM, Dawson-Hughes B (2002) Household tobacco smoke exposure is negatively associated with premenopausal bone mass. Osteoporos Int 13:663–668
Yolton K, Dietrich K, Auinger P, Lanphear BP, Hornung R (2005) Exposure to environmental tobacco smoke and cognitive abilities among U.S. children and adolescents. Environ Health Perspect 113:98–103
Collins BN, Wileyto EP, Murphy MF, Munafo MR (2007) Adolescent environmental tobacco smoke exposure predicts academic achievement test failure. J Adolesc Health 41:363–370
Hooper SR, Gerson AC, Butler RW, Gipson DS, Mendley SR, Lande MB, Shinnar S, Wentz A, Matheson M, Cox C, Furth SL, Warady BA (2011) Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease. Clin J Am Soc Nephrol 6:1824–1830
Omoloja A, Abraham A, Matheson M, Mitsnefes M, Furth S, Warady B, Gerson AC (2012) Association between second-hand smoking exposure, neurocognitive functioning and HRQoL in children with CKD. E-PAS2012:2910.138
Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW, Gipson DS, Lande MB, Shinnar S, Moxey-Mims MM, Warady BA, Furth SL (2010) Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics 125:e349–e357
Weeks SG, Glantz SA, De Marco T, Rosen AB, Fleischmann KE (2011) Secondhand smoke exposure and quality of life in patients with heart failure. Arch Intern Med 171:1887–1893
Bridevaux PO, Cornuz J, Gaspoz JM, Burnand B, Ackermann-Liebrich U, Schindler C, Leuenberger P, Rochat T, Gerbase MW, SAPALDIA Team (2007) Secondhand smoke and health-related quality of life in never smokers: results from the SAPALDIA cohort study 2. Arch Intern Med 167:2516–2523
Dube SR, Thompson W, Homa DM, Zack MM (2013) Smoking and health-related quality of life among U.S. adolescents. Nicotine Tob Res 15:492–500
Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN (2000) Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 36:167–176
Kroon LA (2007) Drug interactions with smoking. Am J Health Syst Pharm 64:1917–1921
Schein JR (1995) Cigarette smoking and clinically significant drug interactions. Ann Pharmacother 29:1139–1148
Agaku IT, Ayo-Yusuf OA, Vardavas CI, Alpert HR, Connolly GN (2013) Use of conventional and novel smokeless tobacco products among US adolescents. Pediatrics 132:E578–E586
Agaku IT, Vardavas CI, Ayo-Yusuf OA, Alpert HR, Connolly GN (2013) Temporal trends in smokeless tobacco use among US middle and high school students, 2000–2011. JAMA 309:1992–1994
Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W (2007) Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med 262:351–359
Hergens MP, Lambe M, Pershagen G, Terent A, Ye W (2008) Smokeless tobacco and the risk of stroke. Epidemiology 19:794–799
Hergens MP, Lambe M, Pershagen G, Ye W (2008) Risk of hypertension amongst Swedish male snuff users: a prospective study. J Intern Med 264:187–194
Akar H, Akar GC, Carrero JJ, Stenvinkel P, Lindholm B (2011) Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol 6:218–226
Avila-Tang E, Al-Delaimy WK, Ashley DL, Benowitz N, Bernert JT, Kim S, Samet JM, Hecht SS (2013) Assessing secondhand smoke using biological markers. Tob Control 22:164–171
Benowitz NL, Hukkanen J, Jacob P 3rd (2009) Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 192:29–60
Molander L, Hansson A, Lunell E, Alainentalo L, Hoffmann M, Larsson R (2000) Pharmacokinetics of nicotine in kidney failure. Clin Pharmacol Ther 68:250–260
Nguyen PT, Galanti L, Pirson Y, Jadoul M (2007) Identification of current smokers among renal transplant recipients. Nephrol Dial Transplant 22:1974–1978
Matt GE, Hovell MF, Quintana PJ, Zakarian J, Liles S, Meltzer SB, Benowitz NL (2007) The variability of urinary cotinine levels in young children: implications for measuring ETS exposure. Nicotine Tob Res 9:83–92
Committee on Environmental HealthHealth, Committee on Substance Abuse, Committee on Adolescence, & Committee on Native American Child (2009) From the American academy of pediatrics: policy statement–tobacco use: a pediatric disease. Pediatrics 124:1474–1487
Bartecchi CE, MacKenzie TD, Schrier RW (1994) The human costs of tobacco use (1). N Engl J Med 330:907–912
Farkas AJ, Gilpin EA, White MM, Pierce JP (2000) Association between household and workplace smoking restrictions and adolescent smoking. JAMA 284:717–722
Wakefield MA, Chaloupka FJ, Kaufman NJ, Orleans CT, Barker DC, Ruel EE (2000) Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ 321:333–337
Choi WS, Gilpin EA, Farkas AJ, Pierce JP (2001) Determining the probability of future smoking among adolescents. Addiction 96:313–323
DiFranza JR, Savageau JA, Fletcher K, O’Loughlin J, Pbert L, Ockene JK, McNeill AD, Hazelton J, Friedman K, Dussault G, Wood C, Wellman RJ (2007) Symptoms of tobacco dependence after brief intermittent use: the development and assessment of nicotine dependence in youth-2 study. Arch Pediatr Adolesc Med 161:704–710
Ursprung WW, DiFranza JR (2010) The loss of autonomy over smoking in relation to lifetime cigarette consumption. Addict Behav 35:14–18
Bruner K, Chand D, Patel H, Stolfi A, Omoloja A (2011) Chronic kidney disease, pediatric nephrologists, and tobacco counseling: perceptions and practice patterns. A study from the midwest pediatric nephrology consortium. J Pediatr 159:155–157
Ehlers SL, Rodrigue JR, Patton PR, Lloyd-Turner J, Kaplan B, Howard RJ (2006) Treating tobacco use and dependence in kidney transplant recipients: development and implementation of a program. Prog Transplant 16:33–37
Patnode CD, O’Connor E, Whitlock EP, Perdue LA, Soh C, Hollis J (2013) Primary care-relevant interventions for tobacco use prevention and cessation in children and adolescents: a systematic evidence review for the U.S. preventive services task force. Ann Intern Med 158:253–260
Rosen LJ, Noach MB, Winickoff JP, Hovell MF (2012) Parental smoking cessation to protect young children: a systematic review and meta-analysis. Pediatrics 129:141–152
Priest N, Roseby R, Waters E, Polnay A, Campbell R, Spencer N, Webster P, Ferguson-Thorne G (2008) Family and carer smoking control programmes for reducing children’s exposure to environmental tobacco smoke. Cochrane Database Syst Rev (4):CD001746. doi:10.1002/14651858.CD001746.pub2
Hovell MF, Meltzer SB, Zakarian JM, Wahlgren DR, Emerson JA, Hofstetter CR, Leaderer BP, Meltzer EO, Zeiger RS, O’Connor RD (1994) Reduction of environmental tobacco smoke exposure among asthmatic children: a controlled trial. Chest 106:440–446
Hovell MF, Zakarian JM, Matt GE, Hofstetter CR, Bernert JT, Pirkle J (2000) Effect of counselling mothers on their children’s exposure to environmental tobacco smoke: Randomised controlled trial. BMJ 321:337–342
Hovell MF, Meltzer SB, Wahlgren DR, Matt GE, Hofstetter CR, Jones JA, Meltzer EO, Bernert JT, Pirkle JL (2002) Asthma management and environmental tobacco smoke exposure reduction in Latino children: a controlled trial. Pediatrics 110:946–956
Emmons KM, Hammond SK, Fava JL, Velicer WF, Evans JL, Monroe AD (2001) A randomized trial to reduce passive smoke exposure in low-income households with young children. Pediatrics 108:18–24
Tyc VL, Huang Q, Nicholson J, Schultz B, Hovell MF, Lensing S, Vukadinovich C, Hudson MM, Zhang H (2013) Intervention to reduce secondhand smoke exposure among children with cancer: a controlled trial. Psychooncology 22:1104–1111
Winickoff JP, Buckley VJ, Palfrey JS, Perrin JM, Rigotti NA (2003) Intervention with parental smokers in an outpatient pediatric clinic using counseling and nicotine replacement. Pediatrics 112:1127–1133
Winickoff JP, Tanski SE, McMillen RC, Hipple BJ, Friebely J, Healey EA (2006) A national survey of the acceptability of quit lines to help parents quit smoking. Pediatrics 117:e695–e700
Winickoff JP, Tanski SE, McMillen RC, Klein JD, Rigotti NA, Weitzman M (2005) Child health care clinicians’ use of medications to help parents quit smoking: a national parent survey. Pediatrics 115:1013–1017
Cluss PA, Moss D (2002) Parent attitudes about pediatricians addressing parental smoking. Ambul Pediatr 2:485–488
Moss D, Cluss PA, Mesiano M, Kip KE (2006) Accessing adult smokers in the pediatric setting: what do parents think? Nicotine Tob Res 8:67–75
Winickoff JP, Hibberd PL, Case B, Sinha P, Rigotti NA (2001) Child hospitalization: an opportunity for parental smoking intervention. Am J Prev Med 21:218–220
Epps RP, Manley MW (1991) A physicians’s guide to preventing tobacco use during childhood and adolescence. Pediatrics 88:140–144
Tyc VL, Rai SN, Lensing S, Klosky JL, Stewart DB, Gattuso J (2003) Intervention to reduce intentions to use tobacco among pediatric cancer survivors. J Clin Oncol 21:1366–1372
Klosky JL, Tyc VL, Hum A, Lensing S, Buscemi J, Garces-Webb DM, Hudson MM (2010) Establishing the predictive validity of intentions to smoke among preadolescents and adolescents surviving cancer. J Clin Oncol 28:431–436
Hoving C, Reubsaet A, de Vries H (2007) Predictors of smoking stage transitions for adolescent boys and girls. Prev Med 44:485–489
Author information
Authors and Affiliations
Corresponding author
Additional information
Answers
1. a
2. d
3. b
4. c
5. b
6. e
Rights and permissions
About this article
Cite this article
Omoloja, A., Tyc, V.L. Tobacco and the pediatric chronic kidney disease population. Pediatr Nephrol 30, 235–243 (2015). https://doi.org/10.1007/s00467-014-2804-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-014-2804-9